Market Access News | pharmaphorum

News

physician holds hand of a person with chronic hand eczema

LEO closes on first approval for chronic hand eczema drug

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

News

In shock move, EU panel rejects Alzheimer's drug Leqembi

The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green lig

News

Pfizer's haemophilia B gene therapy gets EU green light

There will soon be two gene therapies available for patients with haemophilia B in the EU after the European Commission approved Pfizer's fidanacogene elaparvovec under the Durveqtix brand

News

NICE says Boehringer stroke drug 'could save millions'

In new guidance, NICE has cleared NHS use of Boehringer Ingelheim's clot-busting therapy Metalyse as a treatment for acute ischaemic stroke in adults.

News

CVS Caremark president David Joyner, Express Scripts president Adam Kautzner, and OptimRx chief executive Patrick Conway

PBMs under the cosh at House hearing on drug pricing

The top three pharmacy benefit managers in the US felt the heat at a hearing of the House Oversight Committee, as lawmakers grilled executives over their business practices and accused them

News

J&J files to expand label of depression drug Spravato

Johnson & Johnson has filed for FDA approval of its antidepressant nasal spray Spravato, hoping to make it the first standalone treatment for adults with treatment-resistant depression

LEO closes on first approval for chronic hand eczema drug

In shock move, EU panel rejects Alzheimer's drug Leqembi

Pfizer's haemophilia B gene therapy gets EU green light

NICE says Boehringer stroke drug 'could save millions'

PBMs under the cosh at House hearing on drug pricing

J&J files to expand label of depression drug Spravato

Amgen's Imdelltra scores again in small cell lung cancer

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks